Observational studyCancer research communications2024

Association between Immune-Related Adverse Events and Atezolizumab in Previously Treated Patients with Unresectable Advanced or Recurrent Non-Small Cell Lung Cancer.

Hidetoshi Hayashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.